Matt Biegler

Stock Analyst at Oppenheimer

(n/a)
# 4,592
Out of 4,944 analysts
2
Total ratings
n/a
Success rate
-74.62%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Matt Biegler

OnKure Therapeutics
Mar 11, 2025
Maintains: Outperform
Price Target: $35$30
Current: $2.40
Upside: +1,150.00%